Has James Guerra, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,651,630 in general payments to James Guerra, MD across 452 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Guerra, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Guerra, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Guerra, MD

Orthopaedic Surgery · Naples, FLNPI 1437114592

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $2,441,998 of the $2,651,630 with a category attached, or 92.1%. Arthrex accounts for 100.0% of it on its own, with 9 other manufacturers making up the rest. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,651,630in general payments, 2019–2025

Across 452 payments — averaging $5866.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$2.7M
Zimmer Biomet$114
Smith+Nephew$62
Baxter Healthcare$40
Vertex$37
Heraeus Medical, LLC.$23
plus $69 from 4 others

$43,287in research payments, 2019–2025

Across 7 payments — averaging $6183.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Arthrex$43K

What the payments were for

Royalty or licence$2,441,99892%
Consulting fees$133,8755%
Speaking & faculty fees$57,6252%
Travel & lodging$11,4870%
Food & beverage$5,4450%
Education$1,2000%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	439	$2,651,285
Zimmer Biomet	1	$114
Smith+Nephew	2	$62
Baxter Healthcare	3	$40
Vertex	1	$37
Heraeus Medical, LLC.	2	$23
Vericel Corporation	1	$21
Pacira Pharmaceuticals Incorporated	1	$18
Pacira Therapeutics, Inc.	1	$16
Acacia Pharma Inc	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARTHREX$11,373,369
KNEE & HIP SUTURE FIBERLOOP OTHER$167,424
SHOULDER INSTRUMENTS OTHER INSTRUMENTS INSTRUMENT SETS$167,424
KNEE & HIP IMPLANTS SUSPENSORY FIXATION ACL TIGHTROPE$132,279
ARTHROPLASTY INSTRUMENTS SHOULDER ARTHROPLASTY & FRACTURE SUTURE KITS$105,618
ARTHROPLASTY IMPLANTS SHOULDER ARTHROPLASTY & FRACTURE UNIVERS$105,118
ARTHROPLASTY IMPLANTS ANATOMIC TOTAL SHOULDER UNIVERS$62,306
ARTHROPLASTY IMPLANTS ANATOMIC TOTAL SHOULDER SUTURE KITS$62,306
SHOULDER IMPLANTS BICEPS REPAIR FIBERTAK$3,500
ARTHROPLASTY INSTRUMENTS KNEE & HIP ARTHROPLASTY TOTAL KNEE$2,000
KNEE & HIP IMPLANTS HIP FIBERTAK$1,625
CAPITAL CONSUMABLES CONSUMABLES BLADES & BURRS OTHER$1,250
CAPITAL CONSUMABLES CONSUMABLES BLADES & BURRS SPECIALTY$1,000
CAPITAL CONSUMABLES CONSUMABLES RF OTHER$1,000
CAPITAL CONSUMABLES CONSUMABLES BLADES & BURRS SU BURRS$1,000
ARTHROPLASTY IMPLANTS KNEE ARTHROPLASTY TOTAL KNEE$1,000
KNEE & HIP INSTRUMENTS HIP DISPOSABLE$1,000
BIOLOGICS CONSUMABLES BONE REPAIR IOBP$250
ROSA$114

How this compares

$2,651,630 in reported general payments places this provider in the 95th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$1,995,390

Medicare patients

1,644

Services billed

31,183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	302	$4,047
Celecoxib	166	$3,485
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	148	$1,589
Mupirocin	116	$740
Meloxicam	156	$610
Zolpidem Tartrate	170	$560
Methylprednisolone	83	$471
Tramadol Hcl	83	$299
Amoxicillin	96	$294
OxycontinOxycodone Hcl	15	$157
Diclofenac Sodium	13	$114
Ondansetron Hcl	11	$60

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Naples

Jon DounchisNaples$621K
Herbert BertramNaples$349K
Andrew CooperClearwater$102M
Richard HynesMelbourne$34.8M
Mark FrankleTemple Terrace$31M
Roy SandersTemple Terrace$19.6M
George HaidukewychOrlando$10M
Robert SantrockFernandina Beach$7.3M
Martin RocheFt. Lauderdale$7.1M
Steven LyonsTampa$6.7M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →